{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:52:08Z","timestamp":1778615528001,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T00:00:00Z","timestamp":1237420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s11011-009-9136-7","type":"journal-article","created":{"date-parts":[[2009,3,18]],"date-time":"2009-03-18T16:44:25Z","timestamp":1237394665000},"page":"271-282","source":"Crossref","is-referenced-by-count":33,"title":["Effects of 1,4-butanediol administration on oxidative stress in rat brain: Study of the neurotoxicity of \u03b3-hydroxybutyric acid in vivo"],"prefix":"10.1007","volume":"24","author":[{"given":"\u00c2ngela M.","family":"Sgaravatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra S.","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline P.","family":"Mescka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Zanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirian B.","family":"Sgarbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina D.","family":"Pederzolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela T. S.","family":"Wyse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00f3vis M. D.","family":"Wannmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moacir","family":"Wajner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos S.","family":"Dutra-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,19]]},"reference":[{"key":"9136_CR1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H (1984) Catalase in vitro. Meth Enzymol 105:121\u2013126","journal-title":"Meth Enzymol"},{"key":"9136_CR2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0304-3940(01)01636-6","volume":"302","author":"MY Aksenov","year":"2001","unstructured":"Aksenov MY, Markesbery WR (2001) Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer\u2019s disease. Neurosci Lett 302:141\u2013145","journal-title":"Neurosci Lett"},{"key":"9136_CR3","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0024-3205(82)90624-5","volume":"30","author":"J Benavides","year":"1982","unstructured":"Benavides J, Rumigny JF, Bourguignon JJ, Cash C, Wermuth CG, Mandel P, Vincendon G, Maitre M (1982) High affinity binding site for \u03b3-hydroxybutyric acid in rat brain. Life Sci 30:953\u2013961","journal-title":"Life Sci"},{"key":"9136_CR4","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","volume":"73","author":"SB Berman","year":"1999","unstructured":"Berman SB, Hastings TG (1999) Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson\u2019s disease. J Neurochem 73:1127\u20131137","journal-title":"J Neurochem"},{"key":"9136_CR5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(02)01502-9","volume":"441","author":"MA Carai","year":"2002","unstructured":"Carai MA, Colombo G, Reali R, Serra S, Mocci I, Castelli MP et al (2002) Central effects of 1, 4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid. Eur J Pharmacol 441:157\u2013163","journal-title":"Eur J Pharmacol"},{"key":"9136_CR6","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1111\/j.1460-9568.2006.05146.x","volume":"24","author":"LP Carter","year":"2006","unstructured":"Carter LP, Koek W, France CP (2006) Lack of effects of GHB precursors GBL and 1, 4-BD following i.c.v. administration in rats. Eur J Neurosci 24:2595\u20132600","journal-title":"Eur J Neurosci"},{"key":"9136_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0149-7634(94)90031-0","volume":"18","author":"CD Cash","year":"1994","unstructured":"Cash CD (1994) Gammahydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and\/or a useful therapeutic agent. Neurosci Biobehav Rev 18:291\u2013304","journal-title":"Neurosci Biobehav Rev"},{"key":"9136_CR8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.pbb.2004.01.009","volume":"77","author":"CM Fiebre de","year":"2004","unstructured":"de Fiebre CM, de Fiebre NE, Coleman SL, Forster MJ (2004) Comparison of the actions of gamma-butyrolactone and 1, 4-butanediol in Swiss-Webster mice. Pharmacol Biochem Behav 77:705\u2013710","journal-title":"Pharmacol Biochem Behav"},{"key":"9136_CR9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0076-6879(90)86134-H","volume":"186","author":"H Esterbauer","year":"1990","unstructured":"Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407\u2013421","journal-title":"Methods Enzymol"},{"key":"9136_CR10","first-page":"2079","volume-title":"The metabolic and molecular bases of inherited disease","author":"KM Gibson","year":"2001","unstructured":"Gibson KM, Jakobs C (2001) Disorders of beta- and gamma-amino acids in free and peptide-linked forms. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2079\u20132105"},{"key":"9136_CR11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1542\/peds.99.4.567","volume":"99","author":"KM Gibson","year":"1997","unstructured":"Gibson KM, Christensen E, Jakobs C, Fowler B, Clarke MA, Hammersen G et al (1997) The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients. Pediatrics 99:567\u2013574","journal-title":"Pediatrics"},{"key":"9136_CR12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0006-3223(03)00113-6","volume":"54","author":"KM Gibson","year":"2003","unstructured":"Gibson KM, Gupta M, Pearl PL, Tuchman M, Vezina LG, Snead OCIII, Smit LME, Jakobs C (2003) Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria). Biol Psychiatry 54:763\u2013768","journal-title":"Biol Psychiatry"},{"key":"9136_CR13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0026-895X(25)13536-0","volume":"14","author":"DG Graham","year":"1978","unstructured":"Graham DG, Tiffany SM, Bell WR Jr, Gutknecht WF (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 14:644\u2013653","journal-title":"Mol Pharmacol"},{"key":"9136_CR14","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1002\/ana.10625","volume":"54","author":"M Gupta","year":"2003","unstructured":"Gupta M, Hogema BM, Grompe M, Bottiglieri TG, Concas A, Biggio G, Sogliano C, Rigamonti AE, Pearl PL, Snead OCIII, Jakobs C, Gibson KM (2003) Murine succinate semialdehyde dehydrogenase deficiency. Ann Neurol 54:S81\u2013S90","journal-title":"Ann Neurol"},{"key":"9136_CR15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","volume":"18","author":"B Halliwell","year":"2001","unstructured":"Halliwell B (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18:685\u2013716","journal-title":"Drugs Aging"},{"key":"9136_CR16","first-page":"268","volume-title":"Free radicals in biology and medicine","author":"B Halliwell","year":"2007","unstructured":"Halliwell B, Gutteridge JMC (2007) Measurement of reactive species. In: Halliwell B, Gutteridge JMC (eds) Free radicals in biology and medicine. Oxford University Press, Oxford, pp 268\u2013337"},{"key":"9136_CR17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/BF00711902","volume":"16","author":"C Jakobs","year":"1993","unstructured":"Jakobs C, Jaeken J, Gibson KM (1993) Inherited disorders of GABA metabolism. J Inherit Metab Dis 16:704\u2013715","journal-title":"J Inherit Metab Dis"},{"key":"9136_CR18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbadis.2006.01.006","volume":"1762","author":"EE Jansen","year":"2006","unstructured":"Jansen EE, Verhoeven NM, Jakobs C et al (2006) Increased guanidino species in murine and human succinate semialdehyde dehydrogenase (SSADH) deficiency. Biochim Biophys Acta 1762:494\u2013498","journal-title":"Biochim Biophys Acta"},{"key":"9136_CR19","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/0006-2952(90)90581-5","volume":"40","author":"EE Kaufman","year":"1990","unstructured":"Kaufman EE, Porrino LJ, Nelson T (1990) Pyretic action of low doses of gammahydroxybutyrate in rats. Biochem Pharmacol 40:2637\u20132640","journal-title":"Biochem Pharmacol"},{"key":"9136_CR20","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/BF00965839","volume":"16","author":"EE Kaufman","year":"1991","unstructured":"Kaufman EE, Nelson T (1991) An overview of \u03b3-hydroxybutyrate catabolism: the role of the cytosolic NADP+-dependent oxidoreductase EC 1.1.1.19 and of a mitochondrial hydroxyacid-oxoacid transhydrogenase in the initial, rate-limiting step in this pathway. Neurochem Res 16:965\u2013974","journal-title":"Neurochem Res"},{"key":"9136_CR21","doi-asserted-by":"crossref","first-page":"16872","DOI":"10.1016\/S0021-9258(18)37472-6","volume":"263","author":"EE Kaufman","year":"1998","unstructured":"Kaufman EE, Nelson T, Fales HM, Levin DM (1998) Isolation and characterization of a hydroxyacid-oxoacid transhydrogenase from rat kidney mitochondria. J Biol Chem 263:16872\u201316879","journal-title":"J Biol Chem"},{"key":"9136_CR22","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1046\/j.1460-9568.2003.02639.x","volume":"17","author":"A Latini","year":"2003","unstructured":"Latini A, Scussiato K, Rosa RB et al (2003) D-2-hydroxyglutaric acid induces oxidative stress in cerebral cortex of young rats. Eur J Neurosci 17:2017\u20132022","journal-title":"Eur J Neurosci"},{"key":"9136_CR23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s10545-007-0599-6","volume":"30","author":"A Latini","year":"2007","unstructured":"Latini A, Scussiato K, Leipnitz G, Gibson KM, Wajner M (2007) Evidence for oxidative stress in tissues derived from succinate semialdehyde dehydrogenase-deficient mice. J Inherit Metab Dis 30:800\u2013810","journal-title":"J Inherit Metab Dis"},{"key":"9136_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0748-5514(86)90125-X","volume":"2","author":"E Lissi","year":"1986","unstructured":"Lissi E, Caceres T, Videla LA (1986) Visible chemiluminescence from rat homogenates undergoing autoxidation. I. Effect of additives and products acummulation. J Free Radic Biol Med 2:63\u201369","journal-title":"J Free Radic Biol Med"},{"key":"9136_CR25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0891-5849(94)00117-3","volume":"18","author":"E Lissi","year":"1995","unstructured":"Lissi E, Salim-Hanna M, Pascual C, Del Castillo MD (1995) Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med 18:153\u2013158","journal-title":"Free Radic Biol Med"},{"key":"9136_CR26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/030089168507100305","volume":"71","author":"SF Llesuy","year":"1985","unstructured":"Llesuy SF, Milei J, Molina H, Boveris A, Milei S (1985) Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4\u2032-epiadriamycin in mice. Tumori 71:241\u2013249","journal-title":"Tumori"},{"key":"9136_CR27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"9136_CR28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","volume":"51","author":"M Maitre","year":"1997","unstructured":"Maitre M (1997) The \u03b3-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 51:337\u2013361","journal-title":"Prog Neurobiol"},{"key":"9136_CR29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0741-8329(99)00092-0","volume":"20","author":"M Maitre","year":"2000","unstructured":"Maitre M, Andriamampandry C, Kemmel V, Schmidt C, Hod\u00e9 Y, Hechler V, Gobaille S (2000) Gamma-hydroxybutyric acid as a signaling molecule in brain. Alcohol 20:277\u2013283","journal-title":"Alcohol"},{"key":"9136_CR30","first-page":"243","volume-title":"Handbook of methods for oxygen radical research","author":"SL Marklund","year":"1985","unstructured":"Marklund SL (1985) Pyrogallol autoxidation. In: Greenwald RA (ed) Handbook of methods for oxygen radical research. CRC, Boca Raton, pp 243\u2013247"},{"key":"9136_CR31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1471-4159.2003.01839.x","volume":"86","author":"TC Murphy","year":"2003","unstructured":"Murphy TC, Amarnath V, Gibson KM, Picklo MJ Sr (2003) Oxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (ALDH5A). J Neurochem 86:298\u2013305","journal-title":"J Neurochem"},{"key":"9136_CR32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0925-4439(02)00220-X","volume":"1637","author":"E Nguyen","year":"2003","unstructured":"Nguyen E, Picklo MJ (2003) Inhibition of succinic semialdehyde dehydrogenase activity by alkenal products of lipid peroxidation. Biochim Biophys Acta 1637:107\u2013112","journal-title":"Biochim Biophys Acta"},{"key":"9136_CR33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358","journal-title":"Anal Biochem"},{"key":"9136_CR34","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1002\/ana.10629","volume":"54","author":"PL Pearl","year":"2003","unstructured":"Pearl PL, Novotny EJ, Acosta MT, Jakobs C, Gibson KM (2003) Succinic semialdehyde dehydrogenase deficiency in children and adults. Ann Neurol 54:S73\u2013S80","journal-title":"Ann Neurol"},{"key":"9136_CR35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0028-3908(84)90226-0","volume":"23","author":"F Poldrugo","year":"1984","unstructured":"Poldrugo F, Snead OC (1984) 1, 4-Butanediol, \u03b3-hydroxybutyric acid and ethanol: relationships and interactions. Neuropharmacology 23:109\u2013113","journal-title":"Neuropharmacology"},{"key":"9136_CR36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0024-3205(02)01744-7","volume":"71","author":"LS Quang","year":"2002","unstructured":"Quang LS, Shannon MW, Woolf AD, Desai MC, Maher TJ (2002) Pretreatment of CD-1 mice with 4-methylpyrazole blocks toxicity from the gamma-hydroxybutyrate precursor, 1, 4-butanediol. Life Sci 71:771\u2013778","journal-title":"Life Sci"},{"key":"9136_CR37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","volume":"233","author":"AZ Reznick","year":"1994","unstructured":"Reznick AZ, Packer L (1994) Oxidative damage to proteins: Spectrophotometric method for carbonyl assay. Meth Enzymol 233:357\u2013363","journal-title":"Meth Enzymol"},{"key":"9136_CR38","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0006-2952(68)90010-5","volume":"17","author":"RH Roth","year":"1968","unstructured":"Roth RH, Giarman NJ (1968) Evidence that central nervous system depression by 1, 4-butanediol is mediated through a metabolite, gamma-hydroxybutyrate. Biochem Pharmacol 17:735\u2013739","journal-title":"Biochem Pharmacol"},{"key":"9136_CR39","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.neuint.2006.12.009","volume":"50","author":"SW Sauer","year":"2007","unstructured":"Sauer SW, K\u00f6lker S, Hoffmann GF, Ten Brink HJ, Jakobs C, Gibson KM, Okun JG (2007) Enzymatic and metabolic evidence for a region specific mitochondrial dysfunction in brains of murine succinic semialdehyde dehydrogenase deficiency (Aldh5a1-\/- mice). Neurochem Int 50:653\u2013659","journal-title":"Neurochem Int"},{"key":"9136_CR40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neuint.2006.11.007","volume":"50","author":"AM Sgaravatti","year":"2007","unstructured":"Sgaravatti AM, Sgarbi MB, Testa CG, Durigon K, Pederzolli CD, Prestes CC, Wyse AT, Wannmacher CM, Wajner M, Dutra-Filho CS (2007) Gamma-hydroxybutyric acid induces oxidative stress in cerebral cortex of young rats. Neurochem Int 50:564\u2013570","journal-title":"Neurochem Int"},{"key":"9136_CR41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00006565-200012000-00017","volume":"16","author":"M Shannon","year":"2000","unstructured":"Shannon M, Quang LS (2000) Gamma-hydroxybutyrate, gamma-butyrolactone, and 1, 4-butanediol: a case report and review of the literature. Pediatr Emerg Care 16:435\u2013440","journal-title":"Pediatr Emerg Care"},{"key":"9136_CR42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1020658624567","volume":"14","author":"AR Silva","year":"1999","unstructured":"Silva AR, Ruschel C, Helegda C, Brusque AM, Wannmacher CMD, Wajner M, Dutra-Filho CS (1999) Inhibition of rat brain lipid synthesis in vitro by 4-hydroxybutyrir acid. Metab Brain Dis 14:157\u2013164","journal-title":"Metab Brain Dis"},{"key":"9136_CR43","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1056\/NEJMra044047","volume":"352","author":"OC Snead","year":"2005","unstructured":"Snead OC, Gibson KM (2005) Gamma-hydroxybutyric acid. N Engl J Med 352:2721\u20132732","journal-title":"N Engl J Med"},{"key":"9136_CR44","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/0006-2952(84)90629-4","volume":"33","author":"OC Snead","year":"1984","unstructured":"Snead OC, Liu CC (1984) Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochem Pharmacol 33:2587\u20132590","journal-title":"Biochem Pharmacol"},{"key":"9136_CR45","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/0006-2952(89)90645-X","volume":"38","author":"OC Snead","year":"1989","unstructured":"Snead OC, Furner R, Liu CC (1989) In vivo conversion of \u03b3-aminobutyric acid and 1, 4-butanediol to \u03b3-hydroxybutyric acid in rat brain. Biochem Pharmacol 38:4375\u20134380","journal-title":"Biochem Pharmacol"},{"key":"9136_CR46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.metabol.2005.09.009","volume":"55","author":"EA Struys","year":"2006","unstructured":"Struys EA, Verhoeven NM, Jansen EE, Ten Brink HJ, Gupta M, Burlingame TG, Quang LS, Maher T, Rinaldo P, Snead OC, Goodwin AK, Weerts EM, Brown PR, Murphy TC, Picklo MJ, Jakobs C, Gibson KM (2006a) Metabolism of gamma-hydroxybutyrate to d-2-hydroxyglutarate in mammals: further evidence for d-2-hydroxyglutarate transhydrogenase. Metabolism 55:353\u2013358","journal-title":"Metabolism"},{"key":"9136_CR47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ymgme.2005.12.002","volume":"88","author":"EA Struys","year":"2006","unstructured":"Struys EA, Verhoeven NM, Salomons GS, Berthelot J, Vianay-Saban C, Chabrier S, Thomas JA, Tsai AC, Gibson KM, Jakobs C (2006b) D-2-hydroxyglutaric aciduria in three patients with proven SSADH deficiency: genetic coincidence or a related biochemical epiphenomenon? Mol Genet Metab 88:53\u201357","journal-title":"Mol Genet Metab"},{"key":"9136_CR48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03033289","volume":"1","author":"D Sulzer","year":"2000","unstructured":"Sulzer D, Zecca L (2000) Intraneuronal dopamine-quinone synthesis: a review. Neurotox Res 1:181\u2013195","journal-title":"Neurotox Res"},{"key":"9136_CR49","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1592\/phco.21.20.1486.34472","volume":"21","author":"CJ Teter","year":"2001","unstructured":"Teter CJ, Guthrie SK (2001) A comprehensive review of MDMA and GHB: two common club drugs. Pharmacotherapy 21:1486\u20131513","journal-title":"Pharmacotherapy"},{"key":"9136_CR50","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0306-3623(92)90282-O","volume":"23","author":"G Tunnicliff","year":"1992","unstructured":"Tunnicliff G (1992) Significance of \u03b3-hydroxybutyric acid in the brain. Gen Pharmacol 23:1027\u20131034","journal-title":"Gen Pharmacol"},{"key":"9136_CR51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0076-6879(81)77046-0","volume":"77","author":"A Wendel","year":"1981","unstructured":"Wendel A (1981) Glutathione peroxidase. Meth Enzymol 77:325\u2013333","journal-title":"Meth Enzymol"},{"key":"9136_CR52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tips.2003.11.001","volume":"25","author":"CGT Wong","year":"2004","unstructured":"Wong CGT, Gibson KM, Snead OCIII (2004) From the street to the brain: neurobiology of the recreational drug \u03b3-hydroxybutyric acid. Trends Pharmacol Sci 25:29\u201334","journal-title":"Trends Pharmacol Sci"},{"key":"9136_CR53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijdevneu.2004.05.002","volume":"22","author":"AI Zugno","year":"2004","unstructured":"Zugno AI, Franzon R, Chiarani F, Bavaresco CS, Wannmacher CM, Wajner M, Wyse AT (2004) Evaluation of the mechanism underlying the inhibitory effect of guanidinoacetate on brain Na+, K+-ATPase activity. Int J Dev Neurosci 22:191\u2013196","journal-title":"Int J Dev Neurosci"},{"key":"9136_CR54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11011-006-9003-8","volume":"21","author":"AI Zugno","year":"2006","unstructured":"Zugno AI, Scherer EB, Schuck PF, Oliveira DL, Wofchuck S, Wannmacher CM, Wajner M, Wyse AT (2006) Intrastriatal administration of guanidinoacetate inhibits Na+, K+-ATPase and creatine kinase activities in rat striatum. Metab Brain Dis 21:41\u201350","journal-title":"Metab Brain Dis"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-009-9136-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-009-9136-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-009-9136-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T14:08:27Z","timestamp":1739023707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-009-9136-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,19]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["9136"],"URL":"https:\/\/doi.org\/10.1007\/s11011-009-9136-7","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,19]]}}}